The Role of Activating and Inhibitory NK Cell Receptors in Antitumor Immune Response
Open Access
- 13 December 2017
- book chapter
- Published by IntechOpen
Abstract
Natural killer (NK) cells express many newly identified activating and inhibitory receptors that upon engagement by cognate ligands on target tumor cells regulate NK cell antitumor activity. Recently, several paired NK cell receptor families that include receptors with similar binding specificities but opposite function have been defined. The expression of most important activating receptors, natural killer group 2D (NKG2D), natural cytotoxic receptors (NCR), DNAX accessory molecule-1 (DNAM1) and activating killer cell immunoglobulin-like receptors (KAR) is often decreased, while the expression of most prominent inhibitory NK cell receptors, killer cell inhibitory immunoglobulin-like receptors (KIR) and CD94/NKG2A, may occasionally be increased in malignancies. These data indicate that impaired NK cell antitumor response results from NK cell receptor alterations induced by suppressive factors in the tumor microenvironment, including cytokines, growth factors, enzymes and metabolites, as well as by chronic NK cell receptor engagement by the tumor. The established alterations in NK cell receptor expression in cancer patients represent potential disease biomarkers and may aid in choosing therapies that upregulate activating or block inhibitory receptor function. Accumulating knowledge of NK cell biology has been helpful in creating novel therapeutic approaches that by release from tumor-influenced immunosuppression potentiate NK cell activity in cancer patients.Keywords
This publication has 77 references indexed in Scilit:
- Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional ImplicationsScandinavian Journal of Immunology, 2013
- The Tumor Microenvironment: A Pitch for Multiple PlayersFrontiers in Oncology, 2013
- Shaping of NK Cell Responses by the Tumor MicroenvironmentCancer Microenvironment, 2012
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumorsJournal of Experimental Medicine, 2012
- Regulation of immune cell function and differentiation by the NKG2D receptorCellular and Molecular Life Sciences, 2011
- Increased killer immunoglobulin‐like receptor expression and functional defects in natural killer cells in lung cancerImmunology, 2011
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicityProceedings of the National Academy of Sciences, 2009
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansJournal of Experimental Medicine, 2009
- Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in diseaseClinical and Experimental Immunology, 2007
- Impaired Natural Killer Cell Lysis in Breast Cancer Patients with High Levels of Psychological Stress is Associated with Altered Expression of Killer Immunoglobin-Like ReceptorsJournal of Surgical Research, 2007